|
Volumn 17, Issue 4, 2006, Pages 448-454
|
Clinical trial design issues raised during recombinant DNA advisory committee review of gene transfer protocols
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT DNA;
CLINICAL PROTOCOL;
DRUG MONITORING;
DRUG SAFETY;
GENE TRANSFER;
HUMAN;
MEDICAL RESEARCH;
PATIENT SAFETY;
PATIENT SELECTION;
RECOMBINANT DNA TECHNOLOGY;
REVIEW;
STATISTICAL ANALYSIS;
CLINICAL PROTOCOLS;
CLINICAL TRIALS;
ETHICS COMMITTEES, RESEARCH;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GOVERNMENT REGULATION;
HUMANS;
META-ANALYSIS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 33645953638
PISSN: 10430342
EISSN: None
Source Type: Journal
DOI: 10.1089/hum.2006.17.448 Document Type: Review |
Times cited : (9)
|
References (13)
|